Beth Hahn

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 11

Top Topics

Chronic Obstructive Pulmonary Disease

Randomized Controlled Trial

Top Venues

Pulmonary therapy

International journal of chronic obstructive pulmonary disease

Journal of asthma and allergy

BMC pulmonary medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Neil Bhattacharyya, Jared Silver, Michael Bogart, Kalé Kponee-Shovein, Wendy Y Cheng, Mu Cheng, Hoi Ching Cheung, Mei Sheng Duh, Beth Hahn
Profiling Disease and Economic Burden in CRSwNP Using Machine Learning. Journal of asthma and allergy 15 (2022)
David Slade, Riju Ray, Chad Moretz, Guillaume Germain, François Laliberté, Qin Shen, Mei Sheng Duh, Malena Mahendran, Beth Hahn
Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study. BMC pulmonary medicine 21 (1) (2021)
Ravi Kalhan, David Slade, Riju Ray, Chad Moretz, Guillaume Germain, François Laliberté, Qin Shen, Mei Sheng Duh, Sean Dale MacKnight, Beth Hahn
Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities. International journal of chronic obstructive pulmonary disease 16 (2021)
David Slade, Riju Ray, Chad Moretz, Guillaume Germain, François Laliberté, Qin Shen, Mei Sheng Duh, Sean D MacKnight, Beth Hahn
Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease. Pulmonary therapy 7 (1) (2021)
Jean-Pierre Llanos, Hector Ortega, Michael Bogart, Elizabeth R Packnett, Janna Manjelievskaia, Christopher F Bell, Beth Hahn
Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs. Journal of asthma and allergy 13 (2020)
Jared Silver, Michael Bogart, Elizabeth Packnett, Juan Wu, Donna McMorrow, Beth Hahn
Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma. Journal of asthma and allergy 13 (2020)
Chad Moretz, Ashley L Cole, George Mu, Benjamin Wu, Amy Guisinger, Yunhao Liu, Beth Hahn, Lee Baylis
Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy. International journal of chronic obstructive pulmonary disease 15 (2020)
Chad Moretz, Beth Hahn, John White, Alyssa Goolsby Hunter, Breanna Essoi, Caitlin Elliott, Riju Ray
Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy. International journal of chronic obstructive pulmonary disease 15 (2020)
Beth Hahn, Richard H Stanford, Alyssa Goolsby Hunter, John White, Breanna Essoi, Riju Ray
Predictors of Symptom Burden in Patients with COPD on LAMA Monotherapy: Multivariable Analysis of a Claims-Linked Survey Study. Pulmonary therapy 5 (2) (2019)
Beth Hahn, Richard H Stanford, Alyssa Goolsby Hunter, Breanna Essoi, John White, Riju Ray
Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study. Pulmonary therapy 5 (1) (2019)
Riju Ray, Beth Hahn, Richard H Stanford, John White, Breanna Essoi, Alyssa Goolsby Hunter
Classification of Patients with COPD on LAMA Monotherapy Using the GOLD Criteria: Analysis of a Claims-Linked Patient Survey Study. Pulmonary therapy 5 (2) (2019)